What makes BPC-157 distinctive among research peptides is a combination of three properties rarely found together: it has no sequence homology to any other known peptide, it is completely stable in human gastric acid for at least 24 hours (unlike most growth factors and peptide analogues, which are rapidly degraded), and it remains active across an exceptionally broad effective dose range from nanogram to microgram per kilogram bodyweight in pre-clinical models without any known toxic dose having been established in animal studies to date
Competitive athletes subject to WADA testing or other drug testing programs, as BPC-157 is classified as a prohibited substance under WADA's S0 category
Mutation at Cys2991 abolishes redox sensitivity while maintaining activation by DNA damage
Here are the three neuropeptides available in our catalog
The programme launches July 1, 2026, and runs through December 31, 2027
Initial research is highly concerning that these medications have side effects that need further research before widespread drug administration and adoption, significantly decrease muscle mass, and can cause significant weight gain after stopping
